Showing results (41-50 of 174) with videos related to
Sort By:
Pageof 18
Pharmacological Research|February 28, 2016
Using CTCs for pharmacogenomic analysisChristopher D Hart, Francesca Galardi, Marta Pestrin, et al.Breast (Edinburgh, Scotland)|October 22, 2011
Adjuvant systemic treatment for individual patients with triple negative breast cancerCatherine Oakman, Erica Moretti, Francesca Galardi, et al.Breast (Edinburgh, Scotland)|November 17, 2009
Adjuvant chemotherapy--the dark side of clinical trials. Have we learnt more?Catherine Oakman, Marta Pestrin, Egidia Cantisani, et al.Critical Reviews in Oncology/Hematology|March 21, 2012
Metabolomics in cancer: a bench-to-bedside intersectionWederson M Claudino, Priscila H Goncalves, Angelo di Leo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Prognostic and predictive value of HER2 extracellular domain in metastatic breast cancer treated with lapatinib and paclitaxel in a randomized phase III studyRichard S Finn, Robert Gagnon, Angelo Di Leo, et al.The International Journal of Biochemistry & Cell Biology|May 13, 2010
Uncovering the metabolomic fingerprint of breast cancerCatherine Oakman, Leonardo Tenori, Laura Biganzoli, et al.Cancer Treatment Reviews|January 11, 2015
A new era of improving progression-free survival with dual blockade in postmenopausal HR(+), HER2(-) advanced breast cancerGuy Jerusalem, Thomas Bachelot, Carlos Barrios, et al.The EPMA Journal|September 3, 2015
Discovery of novel mutations in the dihydropyrimidine dehydrogenase gene associated with toxicity of fluoropyrimidines and viewpoint on preemptive pharmacogenetic screening in patientsMarzia Del Re, Angela Michelucci, Angelo Di Leo, et al.Critical Reviews in Oncology/Hematology|March 6, 2016
Endocrine therapy in post-menopausal women with metastatic breast cancer: From literature and guidelines to clinical practiceValentina Sini, Saverio Cinieri, Pierfranco Conte, et al.Therapeutic Advances in Medical Oncology|June 15, 2018
The role of abemaciclib in treatment of advanced breast cancerAmelia McCartney, Erica Moretti, Giuseppina Sanna, et al.Pageof 18